HPV testing at Fujirebio
Since our founding in 1950, we have developed and provided trusted and innovative IVD testing solutions that empower healthcare professionals with accurate insights that allows for the most clinically dependable outcomes of patients – outcomes that affect their future.
Since the 1990's our molecular testing solutions have been recognized for their high quality. We have recently extended our molecular testing portfolio and are now pleased to also offer methylation testing technology. Methylation testing raises accuracy and reliability to an art form that can make a decisive difference in the lives of millions of patients across the world.
Our reliable and accurate solutions for molecular test laboratories today include:
- Hepatitis B virus
- Hepatitis C virus
- Human papillomavirus
- Mycobacteria
- Sexually transmitted infections
- Urinary tract infections
Our portfolio of HPV testing solutions eases the burden on clinicians and patients, through improved screening, accurate triage, and identification of high-risk patients in need of treatment and through precise genotyping, when needed.
We have collected resources and reading material related to our HPV testing portfolio and offer below. Please feel free to contact us today if you were to have any questions or wish to discuss how we can collaborate.
Insights
EUROGIN 2024 – key takeaway messages
The annual EUROGIN conference covers a dense scientific program on the topic of Human papillomavirus (HPV) and its associated cancers, always with a...
Scientific poster – Inter- and intra-laboratory reproducibility of the AmpFire® HPV Screening 16/18/HR assay
This poster summarizes the investigation of the reproducibility (within a laboratory and between laboratories) of the AmpFire HPV Screening 16/18/HR...
A risk-based approach for post-treatment detection of recurrent CIN
This article describes how HPV genotyping and DNA methylation analysis can help discriminate women in need of re-treatment from those who can be...
Video: DNA methylation and improved detection of cervical pre-cancers in screening, diagnosis and post-treatment management
In this short video you will find out how DNA methylation plays a crucial role in cancer development. And how the PreCursor-M+ assay, measuring the...
Better care for pregnant women diagnosed with precancerous cervical lesions
Cervical cancer is the most common malignancy of the female reproductive tract during pregnancy occurring in 1 to 10 per 10 000 pregnancies with an...
Cervical cancer screening being reviewed – the role of distinguishing individual HPV genotypes
Cervical screening guidelines are being reviewed and changed in response to new evidence as it becomes available. At EU level the cancer screening...
Improved triage with FAM19A4/miR124-2 methylation analysis - clinical assurance thanks to objective and reliable results
Studies demonstrate FAM19A4/miR124-2 methylation can be considered as an alternative to cytology as follow-up test for hrHPV positive women given its...
EUROGIN 2023 - Shared challenges to the implementation of HPV screening and diagnostics from research to practice
The keynote lectures by prominent experts in their respective fields at the recent Eurogin 2023 Conference in Bilbao, Spain, once again gave a good...
The interest of SPF10 PCR-based methods for HPV DNA detection in FFPE samples
The past decades, prevalence studies have been done using FFPE (Formalin-fixed-paraffin-embedded) tissue specimens to investigate HPV association with...
Booklet: The Art of Accuracy - Improved triage with FAM19A4/miR124-2 methylation analysis
How does FAM19A4/miR124-2 methylation analysis improve hrHPV positive patient triage and how does it allow a wait-and-see policy? We have prepared an...
Webinar: First void urine & HPV genotyping - Two essential tools to monitor the impact of HPV vaccination programs
The enormous potential of a first void – or initial stream – urine sample becomes evident when we understand it’s composition. In fact, in the case of...
Interview: Urine self sampling could change the world of testing, not only for HPV but also for other oncology markers
Our own Rebecca Millecamps, Marketing Manager at Fujirebio, was interviewed for the podcast series 'Molecules, microbes and multiomics' about the...
INNO-LiPA® HPV Genotyping Extra II for use on self-collected first-void urine samples
HPV (Human Papilloma Virus) is a sexually transmitted virus. Certain genotypes of this virus are known to cause cancers in both men and women, but...
Download our booklet about Improved HPV triage with FAM19A4/miR124-2 methylation analysis
How does FAM19A4/miR124-2 methylation analysis improve hrHPV positive patient triage and how does it allow a wait-and-see policy? This booklet guides you through some of the key questions you might be asking yourself around the methylation-based testing technology.
Download our booklet about Improved HPV triage with FAM19A4/miR124-2 methylation analysis
How does FAM19A4/miR124-2 methylation analysis improve hrHPV positive patient triage and how does it allow a wait-and-see policy? This booklet guides you through some of the key questions you might be asking yourself around the methylation-based testing technology.